Jubilant Biosys Limited, a wholly-owned subsidiary of

, has received a GST demand order of Rs 13.77 crore for FY 2021-2022 from the Deputy Commissioner of Commercial Taxes in Mysuru, Karnataka. The order includes tax of Rs 6.64 crore, interest of Rs 4.31 crore, and a penalty of Rs 0.66 crore. The dispute concerns Input Tax Credit availment and reversal. Jubilant Pharmova plans to appeal the order, believing it to be legally incorrect. The company expects no financial or operational impact from this development. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.